GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.50
+0.95 (2.40%)
Apr 20, 2026, 1:16 PM CST

GeneFerm Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,6402,0001,9493,0892,7741,809
Market Cap Growth
-29.38%2.66%-36.91%11.36%53.33%122.87%
Enterprise Value
1,6842,0532,0853,1722,8421,711
Last Close Price
39.5548.2547.0072.1763.9041.33
PE Ratio
56.8169.31-24.7929.6831.51
PS Ratio
2.422.953.743.894.383.46
PB Ratio
2.012.452.473.463.342.42
P/TBV Ratio
2.012.452.483.473.342.42
P/FCF Ratio
21.6126.36-25.66--
P/OCF Ratio
16.5120.14240.8716.2322.6516.12
EV/Sales Ratio
2.493.034.004.004.483.28
EV/EBITDA Ratio
13.9718.0955.0214.4619.5814.53
EV/EBIT Ratio
36.5444.55-20.6627.8621.70
EV/FCF Ratio
22.1927.05-26.35--
Debt / Equity Ratio
0.400.400.300.140.220.59
Debt / EBITDA Ratio
2.692.695.230.561.193.52
Debt / FCF Ratio
4.274.27-1.06--
Net Debt / Equity Ratio
0.050.050.140.010.10-0.14
Net Debt / EBITDA Ratio
0.390.392.970.030.55-0.87
Net Debt / FCF Ratio
0.580.58-7.860.06-0.523.14
Asset Turnover
0.560.560.450.670.510.45
Inventory Turnover
2.732.732.643.413.202.94
Quick Ratio
2.482.481.781.250.931.50
Current Ratio
3.753.753.072.091.561.78
Return on Equity (ROE)
3.60%3.60%-2.68%14.46%11.84%10.04%
Return on Assets (ROA)
2.37%2.37%-1.85%8.12%5.09%4.29%
Return on Invested Capital (ROIC)
4.47%4.35%-3.82%13.77%11.11%10.78%
Return on Capital Employed (ROCE)
4.10%4.10%-3.40%15.60%10.70%8.90%
Earnings Yield
1.76%1.44%-1.16%4.04%3.37%3.17%
FCF Yield
4.63%3.79%-0.73%3.90%-5.62%-1.80%
Dividend Yield
1.77%1.45%-2.77%2.35%2.42%
Payout Ratio
---49.90%44.36%5.90%
Buyback Yield / Dilution
-0.11%-0.11%0.36%2.26%8.00%-65.83%
Total Shareholder Return
1.66%1.34%0.36%5.04%10.35%-63.41%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.